Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1990 2
1992 1
1993 1
1998 1
1999 2
2001 1
2002 2
2003 1
2004 4
2005 2
2006 3
2007 1
2008 4
2011 1
2014 1
2015 1
2016 3
2017 7
2018 9
2019 12
2020 8
2021 9
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
A Controlled Trial of Erenumab for Episodic Migraine.
Goadsby PJ, Reuter U, Hallström Y, Broessner G, Bonner JH, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA. Goadsby PJ, et al. Among authors: mikol dd. N Engl J Med. 2017 Nov 30;377(22):2123-2132. doi: 10.1056/NEJMoa1705848. N Engl J Med. 2017. PMID: 29171821 Free article. Clinical Trial.
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
Dodick DW, Ashina M, Brandes JL, Kudrow D, Lanteri-Minet M, Osipova V, Palmer K, Picard H, Mikol DD, Lenz RA. Dodick DW, et al. Among authors: mikol dd. Cephalalgia. 2018 May;38(6):1026-1037. doi: 10.1177/0333102418759786. Epub 2018 Feb 22. Cephalalgia. 2018. PMID: 29471679 Clinical Trial.
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators. Kapoor R, et al. Among authors: mikol d. Lancet Neurol. 2018 May;17(5):405-415. doi: 10.1016/S1474-4422(18)30069-3. Epub 2018 Mar 12. Lancet Neurol. 2018. PMID: 29545067 Clinical Trial.
Preventive Therapies for Chronic Migraine.
Goadsby PJ, Picard H, Mikol DD. Goadsby PJ, et al. Among authors: mikol dd. N Engl J Med. 2018 Feb 22;378(8):774-5. doi: 10.1056/NEJMc1716990. N Engl J Med. 2018. PMID: 29469553 No abstract available.
Vascular safety of erenumab for migraine prevention.
Kudrow D, Pascual J, Winner PK, Dodick DW, Tepper SJ, Reuter U, Hong F, Klatt J, Zhang F, Cheng S, Picard H, Eisele O, Wang J, Latham JN, Mikol DD. Kudrow D, et al. Among authors: mikol dd. Neurology. 2020 Feb 4;94(5):e497-e510. doi: 10.1212/WNL.0000000000008743. Epub 2019 Dec 18. Neurology. 2020. PMID: 31852816 Free PMC article.
The changing face of multiple sclerosis clinical trial populations.
Uitdehaag BM, Barkhof F, Coyle PK, Gardner JD, Jeffery DR, Mikol DD. Uitdehaag BM, et al. Among authors: mikol dd. Curr Med Res Opin. 2011 Aug;27(8):1529-37. doi: 10.1185/03007995.2011.591370. Epub 2011 Jun 15. Curr Med Res Opin. 2011. PMID: 21671851 Review.
77 results